ARCHIVES

In Brief: Jennifer Pietenpol Named to IOM Cancer Policy Board

This article is from The Cancer Letter archive.

Vol. 40 No. 29 | July 18, 2014

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

September 30, 1988

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003

AACR Unanimously Backs Tough Antismoking Measure

May 18, 1984